Titre
Corona Immunitas: study protocol of a nationwide program of SARS-CoV-2 seroprevalence and seroepidemiologic studies in Switzerland.
Type
article
Institution
UNIL/CHUV/Unisanté + institutions partenaires
Périodique
Auteur(s)
West, E.A.
Auteure/Auteur
Anker, D.
Auteure/Auteur
Amati, R.
Auteure/Auteur
Richard, A.
Auteure/Auteur
Wisniak, A.
Auteure/Auteur
Butty, A.
Auteure/Auteur
Albanese, E.
Auteure/Auteur
Bochud, M.
Auteure/Auteur
Chiolero, A.
Auteure/Auteur
Crivelli, L.
Auteure/Auteur
Cullati, S.
Auteure/Auteur
d'Acremont, V.
Auteure/Auteur
Epure, A.M.
Auteure/Auteur
Fehr, J.
Auteure/Auteur
Flahault, A.
Auteure/Auteur
Fornerod, L.
Auteure/Auteur
Frank, I.
Auteure/Auteur
Frei, A.
Auteure/Auteur
Michel, G.
Auteure/Auteur
Gonseth, S.
Auteure/Auteur
Guessous, I.
Auteure/Auteur
Imboden, M.
Auteure/Auteur
Kahlert, C.R.
Auteure/Auteur
Kaufmann, L.
Auteure/Auteur
Kohler, P.
Auteure/Auteur
Mösli, N.
Auteure/Auteur
Paris, D.
Auteure/Auteur
Probst-Hensch, N.
Auteure/Auteur
Rodondi, N.
Auteure/Auteur
Stringhini, S.
Auteure/Auteur
Vermes, T.
Auteure/Auteur
Vollrath, F.
Auteure/Auteur
Puhan, M.A.
Auteure/Auteur
Contributrices/contributeurs
Albanese, E.
Amati, R.
Amendola, A.
Anker, D.
Annoni, A.M.
Azman, A.
Bally, F.
Balmer, B.
Baysson, H.
Berthod, D.
Blankenberger, J.
Bochud, M.
Bodenmann, P.
Bopp, M.
Butty, A.
Camerini, A.L.
Cappeli, C.
Carmelli, C.
Chiolero, A.
Collombet, P.
Corna, L.
Crawford, J.
Crivelli, L.
Cullati, S.
Cusini, A.
D'Acremont, V.
De Pietro, C.
Deschamps, A.
Droz, S.
Dumoulin, A.
Duperrex, O.
Dupraz, J.
Egger, M.
Engler, N.
Epure, A.M.
Estoppey, S.
Fadda, M.
Faivre, V.
Fehr, J.
Felappi, A.
Fiordelli, M.
Flahault, A.
Fornerod, L.
Fragoso Corti, C.
Frangville, M.
Frank, I.
Franscella, G.
Frei, A.
Gille, D.
Michel, G.
Gonseth Nusslé, S.
Gouzowski, A.
Guessous, I.
Guggisberg, J.
Günthard, H.
Gutzwiller, F.
Incici, L.
Jendly, E.
Jung, R.
Kahlert, C.
Kaiser, L.
Kaufmann, L.
Kaufmann, M.
Kessler, S.
Kohler, P.
Kriemler, S.
Lenoir, L.
Levati, S.
Maeschli, B.
Magnin, J.L.
Masserey, E.
Morese, R.
Mösli, N.
Noël, N.
Orhant, M.
Pasquier, J.
Pennacchio, F.
Petrovic, D.
Pfister, S.
Picazio, A.
Prandi, C.
Piumatti, G.
Portier, J.
Probst-Hensch, N.
Pugin, C.
Puhan, M.
Radtke, T.
Richard, A.
Robert, C.F.
Rodondi, P.Y.
Rodondi, N.
Salberg, E.
Sanchis Zozaya, J.
Schlüter, V.
Schneider, V.
Steiner-Dubuis, A.
Stringhini, S.
Sumer, J.
Tall, I.
Thabard, J.
Tonolla, M.
Troillet, N.
Ulyte, A.
Vassaux, S.
Vermes, T.
Vollrath, F.
von Wyl, V.
West, E.
Wisniak, A.
Zaballa, M.E.
Zuppinger, C.
Groupes de travail
Corona Immunitas Research Group
Liens vers les personnes
Liens vers les unités
ISSN
1661-8564
Statut éditorial
Publié
Date de publication
2020-12
Volume
65
Numéro
9
Première page
1529
Dernière page/numéro d’article
1548
Peer-reviewed
Oui
Langue
anglais
Notes
Publication types: Journal Article
Publication Status: ppublish
Publication Status: ppublish
Résumé
Seroprevalence studies to assess the spread of SARS-CoV-2 infection in the general population and subgroups are key for evaluating mitigation and vaccination policies and for understanding the spread of the disease both on the national level and for comparison with the international community.
Corona Immunitas is a research program of coordinated, population-based, seroprevalence studies implemented by Swiss School of Public Health (SSPH+). Over 28,340 participants, randomly selected and age-stratified, with some regional specificities will be included. Additional studies in vulnerable and highly exposed subpopulations are also planned. The studies will assess population immunological status during the pandemic.
Phase one (first wave of pandemic) estimates from Geneva showed a steady increase in seroprevalence up to 10.8% (95% CI 8.2-13.9, n = 775) by May 9, 2020. Since June, Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg recruited a total of 5973 participants for phase two thus far.
Corona Immunitas will generate reliable, comparable, and high-quality serological and epidemiological data with extensive coverage of Switzerland and of several subpopulations, informing health policies and decision making in both economic and societal sectors. ISRCTN Registry: https://www.isrctn.com/ISRCTN18181860 .
Corona Immunitas is a research program of coordinated, population-based, seroprevalence studies implemented by Swiss School of Public Health (SSPH+). Over 28,340 participants, randomly selected and age-stratified, with some regional specificities will be included. Additional studies in vulnerable and highly exposed subpopulations are also planned. The studies will assess population immunological status during the pandemic.
Phase one (first wave of pandemic) estimates from Geneva showed a steady increase in seroprevalence up to 10.8% (95% CI 8.2-13.9, n = 775) by May 9, 2020. Since June, Zurich, Lausanne, Basel City/Land, Ticino, and Fribourg recruited a total of 5973 participants for phase two thus far.
Corona Immunitas will generate reliable, comparable, and high-quality serological and epidemiological data with extensive coverage of Switzerland and of several subpopulations, informing health policies and decision making in both economic and societal sectors. ISRCTN Registry: https://www.isrctn.com/ISRCTN18181860 .
Sujets
PID Serval
serval:BIB_620D3186B3A0
PMID
Open Access
Oui
Date de création
2020-11-02T12:08:45.275Z
Date de création dans IRIS
2025-05-20T23:54:32Z
Fichier(s)![Vignette d'image]()
En cours de chargement...
Nom
33098441_BIB_620D3186B3A0.pdf
Version du manuscrit
published
Licence
https://creativecommons.org/licenses/by/4.0
Taille
1.3 MB
Format
Adobe PDF
PID Serval
serval:BIB_620D3186B3A0.P001
URN
urn:nbn:ch:serval-BIB_620D3186B3A08
Somme de contrôle
(MD5):d4e27c2fd31e56fed958c58c23ca0d48